🔎 Trials Near Me

Pradžia › Astma › Texas

Astma klinikiniai tyrimai Texas

20 tyrimai dėl Astma ieško dalyvių vietose Texas.

Miestai Texas

Oficialus tyrimo tekstas (anglų kalba)

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  • GSK Investigational Site, Cypress
  • GSK Investigational Site, Tomball
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07645248

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Kerrville
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-09-30 · NCT05757102

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  • Research Site, Austin
  • Research Site, Boerne
  • Research Site, Dallas
  • ir dar 6
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06932263

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, McKinney
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07301255

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

  • Research Site 17, San Antonio
  • Research Site 07, Sugar Land
Renkami dalyviai3 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07359846

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
  • Horizon Clinical Research Group, Cypress
  • Alina Clinical Trials, LLC., Dallas
  • ir dar 2
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06977581

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  • Research Site, Dallas
  • Research Site, Houston
  • Research Site, San Antonio
Renkami dalyviai3 fazė
Amžius nuo 5 iki 11 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06023589

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  • Research Site 24, Amarillo
  • Research Site 19, Baytown
  • Research Site 07, Dallas
  • ir dar 6
Renkami dalyviai3 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07276724

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • Teva Investigational Site 12083, Austin
  • Teva Investigational Site 12060, Austin
  • Teva Investigational Site 12179, Cypress
  • ir dar 13
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT06664619

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  • Research Site, Lewisville
  • Research Site, San Antonio
Renkami dalyviai2 fazė
Amžius nuo 4 iki 11 · Visoms lytims · Atnaujinta 2026-08-27 · NCT07525375

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  • GSK Investigational Site, San Antonio
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT07456033

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Austin
  • Research Site, Baytown
  • Research Site, Beaumont
  • ir dar 12
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06307665

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

  • GSK Investigational Site, Austin
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-07-29 · NCT07712393

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

  • Research site, Dallas
  • Research site, Houston
  • Research site, San Antonio
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07532265

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

  • Orion Clinical Research, Austin
  • Pharmaceutical Research & Consulting, Inc., Dallas
  • Western Sky Medical Research, El Paso
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 5 iki 100 · Visoms lytims · Atnaujinta 2026-06-02 · NCT07228026

Escitalopram in Asthma Patients With Frequent Exacerbation

  • UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-01-26 · NCT06216535

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

  • Baylor College of Medicine, Houston
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-16 · NCT06273072

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

  • University of Texas at Arlington, Arlington
  • Rebuilding Together North Texas, Plano
Renkami dalyviai
Amžius 5 ir vyresni · Visoms lytims · Atnaujinta 2025-10-29 · NCT07196436

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • JPS Health Network, Fort Worth
  • Kelsey Research Foundation, Houston
Renkami dalyviai4 fazė
Amžius nuo 13 iki 75 · Visoms lytims · Atnaujinta 2025-10-29 · NCT07052942

Viral Mucosal Reprogramming

  • University of Texas Medical Branch, Galveston
Renkami dalyviai2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2025-01-28 · NCT05331170

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.